Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.325 EUR
244.02 M EUR
5.15 B EUR
836.36 M
About SMITH & NEPHEW PLC ORD USD0.20
Sector
Industry
CEO
Deepak S Nath
Website
Headquarters
Watford
Founded
1856
ISIN
GB0009223206
FIGI
BBG000C6N8D5
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
S&N Long.New CFO and medical shares becoming attractive?
Idea only. Don't trade based on my ramblings.
Only risk 1R on any trade.
SNN, Smith & Nephew ADR - Trailing Stop after a breakoutNYSE:SNN
This level had resisted six times.
At the breakout the sellers were clearly few at that point and this was really a must for my strategies.
Let's follow the trend in trailing stop.
SN. Trend continuation?Seems like the pullback is nearly finishing and a beautiful triangle is forming.
Smith and Nephew potential If short term trend line and 1445 can hold good potential bullish If not longer term Trend line could offer good R/R
Medical Tech Mar17With Intuitive, Stryker all up at all time highs i'm hunting for medical robotics companies to acquire.
Smith & Nephew looking for a move below 29 to get long
seekingalpha.com
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SMITH + NEP. DL -,20 stocks are traded under the ticker NPW1.
We've gathered analysts' opinions on SMITH + NEP. DL -,20 future price: according to them, NPW1 price has a max estimate of 17.29 EUR and a min estimate of 11.88 EUR. Watch NPW1 chart and read a more detailed SMITH + NEP. DL -,20 stock forecast: see what analysts think of SMITH + NEP. DL -,20 and suggest that you do with its stocks.
NPW1 reached its all-time high on Feb 20, 2020 with the price of 24.200 EUR, and its all-time low was 4.380 EUR and was reached on Dec 22, 2008. View more price dynamics on NPW1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track SMITH + NEP. DL -,20 financials in yearly and quarterly reports right on TradingView.
SMITH + NEP. DL -,20 is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
NPW1 earnings for the last half-year are 0.35 EUR per share, whereas the estimation was 0.37 EUR, resulting in a −4.28% surprise. The estimated earnings for the next half-year are 0.43 EUR per share. See more details about SMITH + NEP. DL -,20 earnings.
SMITH + NEP. DL -,20 revenue for the last half-year amounts to 2.64 B EUR, despite the estimated figure of 2.64 B EUR. In the next half-year revenue is expected to reach 2.74 B EUR.
NPW1 net income for the last half-year is 199.71 M EUR, while the previous report showed 83.76 M EUR of net income which accounts for 138.43% change. Track more SMITH + NEP. DL -,20 financial stats to get the full picture.
SMITH + NEP. DL -,20 dividend yield was 2.82% in 2023, and payout ratio reached 125.07%. The year before the numbers were 2.82% and 150.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has 19.55 K employees. See our rating of the largest employees — is SMITH + NEP. DL -,20 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SMITH + NEP. DL -,20 EBITDA is 1.40 B EUR, and current EBITDA margin is 26.38%. See more stats in SMITH + NEP. DL -,20 financial statements.
Like other stocks, NPW1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SMITH + NEP. DL -,20 stock right from TradingView charts — choose your broker and connect to your account.